{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:27:38Z","timestamp":1761128858962},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,8,14]],"date-time":"2010-08-14T00:00:00Z","timestamp":1281744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10096-010-1024-x","type":"journal-article","created":{"date-parts":[[2010,8,13]],"date-time":"2010-08-13T10:50:37Z","timestamp":1281696637000},"page":"1475-1479","source":"Crossref","is-referenced-by-count":25,"title":["The importance of a judicious and early empiric choice of antimicrobial for methicillin-resistant Staphylococcus aureus bacteraemia"],"prefix":"10.1007","volume":"29","author":[{"given":"N.","family":"Shime","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,14]]},"reference":[{"key":"1024_CR1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/jama.1994.03510440058033","volume":"271","author":"D Pittet","year":"1994","unstructured":"Pittet D, Tarara D, Wenzel RP (1994) Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271:1598\u20131601","journal-title":"JAMA"},{"key":"1024_CR2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/501795","volume":"21","author":"MJ Richards","year":"2000","unstructured":"Richards MJ, Edwards JR, Culver DH, Gaynes RP (2000) Nosocomial infections in combined medical\u2013surgical intensive care units in the United States. Infect Control Hosp Epidemiol 21:510\u2013515","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1024_CR3","doi-asserted-by":"crossref","first-page":"N64","DOI":"10.1097\/00003246-200104001-00002","volume":"29","author":"SK Fridkin","year":"2001","unstructured":"Fridkin SK (2001) Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med 29:N64\u2013N68","journal-title":"Crit Care Med"},{"key":"1024_CR4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1473-3099(05)70243-7","volume":"5","author":"JM Boyce","year":"2005","unstructured":"Boyce JM, Cookson B, Christiansen K, Hori S, Vuopio-Varkila J, Kocag\u00f6z S, Oztop AY, Vandenbroucke-Grauls CM, Harbarth S, Pittet D (2005) Meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 5:653\u2013663","journal-title":"Lancet Infect Dis"},{"key":"1024_CR5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","volume":"36","author":"SE Cosgrove","year":"2003","unstructured":"Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53\u201359","journal-title":"Clin Infect Dis"},{"key":"1024_CR6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1086\/502522","volume":"26","author":"SE Cosgrove","year":"2005","unstructured":"Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y (2005) The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26:166\u2013174","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1024_CR7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/512627","volume":"28","author":"S Shurland","year":"2007","unstructured":"Shurland S, Zhan M, Bradham DD, Roghmann MC (2007) Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol 28:273\u2013279","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1024_CR8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1086\/502523","volume":"26","author":"SD Reed","year":"2005","unstructured":"Reed SD, Friedman JY, Engemann JJ, Griffiths RI, Anstrom KJ, Kaye KS, Stryjewski ME, Szczech LA, Reller LB, Corey GR, Schulman KA, Fowler VG Jr (2005) Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 26:175\u2013183","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1024_CR9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jac\/dkl017","volume":"57","author":"CG Gemmell","year":"2006","unstructured":"Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, Warren RE; Joint Working Party of the British Society for Joint Working Party of the British Society for Antimicrobial Chemotherapy, Hospital Infection Society and Infection Control Nurses Association (2006) Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 57:589\u2013608","journal-title":"J Antimicrob Chemother"},{"key":"1024_CR10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","volume":"118","author":"EH Ibrahim","year":"2000","unstructured":"Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146\u2013155","journal-title":"Chest"},{"key":"1024_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/00365549709008668","volume":"29","author":"L Leibovici","year":"1997","unstructured":"Leibovici L, Drucker M, Konigsberger H, Samra Z, Harrari S, Ashkenazi S, Pitlik SD (1997) Septic shock in bacteremic patients: risk factors, features and prognosis. Scand J Infect Dis 29:71\u201375","journal-title":"Scand J Infect Dis"},{"key":"1024_CR12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jhin.2006.02.011","volume":"63","author":"AO Guilarde","year":"2006","unstructured":"Guilarde AO, Turchi MD, Martelli CM, Primo MG (2006) Staphylococcus aureus bacteraemia: incidence, risk factors and predictors for death in a Brazilian teaching hospital. J Hosp Infect 63:330\u2013336","journal-title":"J Hosp Infect"},{"key":"1024_CR13","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1248\/bpb.26.876","volume":"26","author":"T Iwamoto","year":"2003","unstructured":"Iwamoto T, Kagawa Y, Kojima M (2003) Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin. Biol Pharm Bull 26:876\u2013879","journal-title":"Biol Pharm Bull"},{"key":"1024_CR14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00134-003-1705-3","volume":"29","author":"SL Kane","year":"2003","unstructured":"Kane SL, Weber RJ, Dasta JF (2003) The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med 29:691\u2013698","journal-title":"Intensive Care Med"},{"key":"1024_CR15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/jac\/45.6.835","volume":"45","author":"I Harding","year":"2000","unstructured":"Harding I, MacGowan AP, White LO, Darley ES, Reed V (2000) Teicoplanin therapy for Staphylococcus aureus septicaemia: relationship between pre-dose serum concentrations and outcome. J Antimicrob Chemother 45:835\u2013841","journal-title":"J Antimicrob Chemother"},{"key":"1024_CR16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10156-006-0446-Y","volume":"12","author":"M Sato","year":"2006","unstructured":"Sato M, Chida K, Suda T, Muramatsu H, Suzuki Y, Hashimoto H, Gemma H, Nakamura H (2006) Recommended initial loading dose of teicoplanin, established by therapeutic drug monitoring, and outcome in terms of optimal trough level. J Infect Chemother 12:185\u2013189","journal-title":"J Infect Chemother"},{"key":"1024_CR17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","volume":"43","author":"PA Moise-Broder","year":"2004","unstructured":"Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ (2004) Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 43:925\u2013942","journal-title":"Clin Pharmacokinet"},{"key":"1024_CR18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00007691-199812000-00005","volume":"20","author":"M Yasuhara","year":"1998","unstructured":"Yasuhara M, Iga T, Zenda H, Okumura K, Oguma T, Yano Y, Hori R (1998) Population pharmacokinetics of vancomycin in Japanese pediatric patients. Ther Drug Monit 20:612\u2013618","journal-title":"Ther Drug Monit"},{"key":"1024_CR19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00007691-199804000-00003","volume":"20","author":"M Yasuhara","year":"1998","unstructured":"Yasuhara M, Iga T, Zenda H, Okumura K, Oguma T, Yano Y, Hori R (1998) Population pharmacokinetics of vancomycin in Japanese adult patients. Ther Drug Monit 20:139\u2013148","journal-title":"Ther Drug Monit"},{"key":"1024_CR20","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1086\/375057","volume":"36","author":"TP Lodise","year":"2003","unstructured":"Lodise TP, McKinnon PS, Swiderski L, Rybak MJ (2003) Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 36:1418\u20131423","journal-title":"Clin Infect Dis"},{"key":"1024_CR21","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/01.CCM.0000227655.41566.3E","volume":"34","author":"GE Schramm","year":"2006","unstructured":"Schramm GE, Johnson JA, Doherty JA, Micek ST, Kollef MH (2006) Methicillin-resistant Staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment. Crit Care Med 34:2069\u20132074","journal-title":"Crit Care Med"},{"key":"1024_CR22","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1345\/aph.1E028","volume":"38","author":"BJ Kopp","year":"2004","unstructured":"Kopp BJ, Nix DE, Armstrong EP (2004) Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Ann Pharmacother 38:1377\u20131382","journal-title":"Ann Pharmacother"},{"key":"1024_CR23","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/AAC.45.9.2460-2467.2001","volume":"45","author":"M Wysocki","year":"2001","unstructured":"Wysocki M, Delatour F, Faurisson F, Rauss A, Pean Y, Misset B, Thomas F, Timsit JF, Similowski T, Mentec H, Mier L, Dreyfuss D (2001) Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother 45:2460\u20132467","journal-title":"Antimicrob Agents Chemother"},{"key":"1024_CR24","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/jac\/47.2.246","volume":"47","author":"JT Wang","year":"2001","unstructured":"Wang JT, Fang CT, Chen YC, Chang SC (2001) Necessity of a loading dose when using vancomycin in critically ill patients. J Antimicrob Chemother 47:246","journal-title":"J Antimicrob Chemother"},{"key":"1024_CR25","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","volume":"166","author":"LK Hidayat","year":"2006","unstructured":"Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A (2006) High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 166:2138\u20132144","journal-title":"Arch Intern Med"},{"key":"1024_CR26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2307\/30142375","volume":"17","author":"JM Mylotte","year":"1996","unstructured":"Mylotte JM, Aeschlimann JR, Rotella DL (1996) Staphylococcus aureus bacteremia: factors predicting hospital mortality. Infect Control Hosp Epidemiol 17:165\u2013168","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1024_CR27","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1086\/317421","volume":"31","author":"JM Mylotte","year":"2000","unstructured":"Mylotte JM, Tayara A (2000) Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 31:1170\u20131174","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1024-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-010-1024-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1024-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:34:20Z","timestamp":1559108060000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-010-1024-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,14]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1024"],"URL":"https:\/\/doi.org\/10.1007\/s10096-010-1024-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2010,8,14]]}}}